Related Experiment Video
Updated: Sep 30, 2025

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
CFTR Suppresses Neointimal Formation Through Attenuating Proliferation and Migration of Aortic Smooth Muscle Cells
Liu-Yi Lu1, Ni Pan1, Ze-Han Huang2
1Institute of Pediatrics, Guangzhou Women and Children's Medical Centre, Guangzhou Medical University, Guangzhou, China.
Abstract:
Cystic fibrosis transmembrane conductance regulator (CFTR) plays important roles in arterial functions and the fate of cells. To further understand its function in vascular remodeling, we examined whether CFTR directly regulates platelet-derived growth factor-BB (PDGF-BB)-stimulated vascular smooth muscle cells (VSMCs) proliferation and migration, as well as the balloon injury-induced neointimal formation. The CFTR adenoviral gene delivery was used to evaluate the effects of CFTR on neointimal formation in a rat model of carotid artery balloon injury. The roles of CFTR in PDGF-BB-stimulated VSMC proliferation and migration were detected by mitochondrial tetrazolium assay, wound healing assay, transwell chamber method, western blot, and qPCR. We found that CFTR expression was declined in injured rat carotid arteries, while adenoviral overexpression of CFTR in vivo attenuated neointimal formation in carotid arteries. CFTR overexpression inhibited PDGF-BB-induced VSMC proliferation and migration, whereas CFTR silencing caused the opposite results. Mechanistically, CFTR suppressed the phosphorylation of PDGF receptor β, serum and glucocorticoid-inducible kinase 1, JNK, p38 and ERK induced by PDGF-BB, and the increased mRNA expression of matrix metalloproteinase-9 and MMP2 induced by PDGF-BB. In conclusion, our results indicated that CFTR may attenuate neointimal formation by suppressing PDGF-BB-induced activation of serum and glucocorticoid-inducible kinase 1 and the JNK/p38/ERK signaling pathway.
Insights
Cystic fibrosis transmembrane conductance regulator (CFTR) attenuates neointimal formation by inhibiting vascular smooth muscle cell proliferation and migration. CFTR suppresses key signaling pathways activated by platelet-derived growth factor-BB (PDGF-BB).
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Vascular Remodeling
Background:
- Cystic fibrosis transmembrane conductance regulator (CFTR) is crucial for arterial function and cellular fate.
- Understanding CFTR's role in vascular remodeling, particularly in response to growth factors and injury, is essential.
Purpose of the Study:
- To investigate whether CFTR directly regulates platelet-derived growth factor-BB (PDGF-BB)-stimulated vascular smooth muscle cell (VSMC) proliferation and migration.
- To determine CFTR's effect on neointimal formation following balloon injury in a rat carotid artery model.
Main Methods:
- Adenoviral gene delivery of CFTR in a rat carotid artery balloon injury model.
- Assessment of VSMC proliferation and migration using mitochondrial tetrazolium assay, wound healing assay, and transwell chamber method.
- Analysis of signaling pathways and gene expression via western blot and quantitative PCR (qPCR).
Main Results:
- CFTR expression decreased in injured rat carotid arteries.
- Overexpression of CFTR attenuated neointimal formation and inhibited PDGF-BB-induced VSMC proliferation and migration.
- CFTR silencing showed opposite effects, and CFTR suppressed PDGF-BB-induced phosphorylation of PDGF receptor β, SGK1, JNK, p38, and ERK, as well as MMP2/9 expression.
Conclusions:
- CFTR plays a significant role in regulating VSMC behavior and vascular remodeling.
- CFTR attenuates neointimal formation by suppressing PDGF-BB-induced activation of SGK1 and the JNK/p38/ERK signaling pathway.
More Related Videos
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
10:57Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta
Published on: September 12, 2017